Diuretic Resistance Prediction and Risk Factor Analysis of Patients with Heart Failure During Hospitalization

Xiao Lu1, Yi Xin1, Jiang Zhu1

  • 1Department of Biomedical Engineering, School of Life Science, Beijing Institute of Technology, Beijing 100081, China.

Global Heart
|July 15, 2022
PubMed

Insights

This study developed a machine learning model to predict diuretic resistance (DR) in decompensated heart failure patients. The model accurately identifies key risk factors like age and pro-brain natriuretic peptide, aiding clinical prediction.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Clinical Prediction Models

Background:

  • Diuretic resistance (DR) is a significant challenge in managing decompensated heart failure (DHF).
  • Predicting and understanding DR risk factors is crucial for effective treatment strategies.

Purpose of the Study:

  • To perform a prediction and risk factor analysis of diuretic resistance (DR) in hospitalized patients with decompensated heart failure.
  • To develop and validate a machine learning model for predicting DR.

Main Methods:

  • Retrospective collection of data from 18,727 patients with DHF (2010-2018).
  • Analysis of baseline characteristics and risk factors using logistic regression.
  • Development and optimization of six machine learning models using Bayesian optimization.
  • Selection of the optimal model based on prediction efficiency.

Main Results:

  • Significant differences in DR incidence were observed related to lung infection, hyperlipidemia, type 2 diabetes, and kidney disease.
  • Key predictors identified include age, abnormal sodium levels, pro-brain natriuretic peptide (pro-BNP), serum albumin, D-dimer, direct bilirubin, and estimated glomerular filtration rate (eGFR).
  • The optimal model achieved an area under the curve (AUC) of 0.9512.

Conclusions:

  • A gradient boosting decision tree model effectively predicts DR risk in DHF patients.
  • The model utilizes simple indicators and provides cutoff values to aid clinicians in predicting DR occurrence.
  • This tool can assist healthcare professionals in identifying high-risk patients for DR.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
476
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
501